Viscofan Cash Flow Conversion Efficiency
Viscofan cash flow conversion efficiency. Based on the latest financial reports, Viscofan (VIS) has a cash flow conversion efficiency ratio of 0.068x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€62.04 Million ≈ $72.54 Million USD) by net assets (€908.61 Million ≈ $1.06 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Viscofan (2004–2025)
Cash flow conversion efficiency of Viscofan from 2004 to 2025. This chart illustrates how Viscofan's cash flow conversion efficiency has evolved over time, based on yearly financial data. View VIS live share price for real-time trading data and today's change.
Viscofan Cash Flow Conversion Ratio Explained
Viscofan cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Viscofan Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Viscofan ranked by their cash flow conversion efficiency. Also see Viscofan market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hang Zhou Iron & Steel Co Ltd
SHG:600126
|
0.124x |
|
K+S Aktiengesellschaft
F:SDF1
|
0.030x |
|
Power Integrations Inc
NASDAQ:POWI
|
0.032x |
|
Russel Metals Inc.
TO:RUS
|
0.066x |
|
Greenland Holdings Corp Ltd
SHG:600606
|
0.021x |
|
Zealand Pharma A/S
CO:ZEAL
|
-0.070x |
|
Winner Medical Co Ltd
SHE:300888
|
0.031x |
|
Home Product Center Public Company Limited
BK:HMPRO
|
0.023x |
Annual Cash Flow Conversion Efficiency for Viscofan (2004–2025)
The table below shows the annual cash flow conversion efficiency of Viscofan from 2004 to 2025. Review Viscofan free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €937.48 Million ≈ $1.10 Billion |
€188.43 Million ≈ $220.30 Million |
0.201x | -19.97% |
| 2024-12-31 | €938.91 Million ≈ $1.10 Billion |
€235.82 Million ≈ $275.70 Million |
0.251x | +65.09% |
| 2023-12-31 | €957.77 Million ≈ $1.12 Billion |
€145.71 Million ≈ $170.35 Million |
0.152x | +14.28% |
| 2022-12-31 | €906.87 Million ≈ $1.06 Billion |
€120.73 Million ≈ $141.14 Million |
0.133x | -50.50% |
| 2021-12-31 | €822.78 Million ≈ $961.91 Million |
€221.30 Million ≈ $258.72 Million |
0.269x | +11.04% |
| 2020-12-31 | €736.25 Million ≈ $860.75 Million |
€178.34 Million ≈ $208.50 Million |
0.242x | +6.78% |
| 2019-12-31 | €784.37 Million ≈ $917.01 Million |
€177.93 Million ≈ $208.02 Million |
0.227x | +37.20% |
| 2018-12-31 | €757.63 Million ≈ $885.74 Million |
€125.27 Million ≈ $146.45 Million |
0.165x | -23.51% |
| 2017-12-31 | €727.68 Million ≈ $850.74 Million |
€157.29 Million ≈ $183.89 Million |
0.216x | +8.92% |
| 2016-12-31 | €708.08 Million ≈ $827.82 Million |
€140.52 Million ≈ $164.28 Million |
0.198x | -8.74% |
| 2015-12-31 | €633.20 Million ≈ $740.28 Million |
€137.70 Million ≈ $160.98 Million |
0.217x | +5.84% |
| 2014-12-31 | €575.87 Million ≈ $673.25 Million |
€118.31 Million ≈ $138.32 Million |
0.205x | -13.39% |
| 2013-12-31 | €521.62 Million ≈ $609.83 Million |
€123.74 Million ≈ $144.66 Million |
0.237x | +13.49% |
| 2012-12-31 | €498.57 Million ≈ $582.88 Million |
€104.21 Million ≈ $121.83 Million |
0.209x | -16.30% |
| 2011-12-31 | €449.44 Million ≈ $525.44 Million |
€112.24 Million ≈ $131.22 Million |
0.250x | -16.45% |
| 2010-12-31 | €406.37 Million ≈ $475.09 Million |
€121.47 Million ≈ $142.01 Million |
0.299x | -16.78% |
| 2009-12-31 | €345.21 Million ≈ $403.58 Million |
€123.99 Million ≈ $144.96 Million |
0.359x | +95.01% |
| 2008-12-31 | €303.27 Million ≈ $354.56 Million |
€55.86 Million ≈ $65.31 Million |
0.184x | -23.10% |
| 2007-12-31 | €295.81 Million ≈ $345.83 Million |
€70.85 Million ≈ $82.83 Million |
0.240x | +87.24% |
| 2006-12-31 | €268.13 Million ≈ $313.47 Million |
€34.30 Million ≈ $40.10 Million |
0.128x | -43.04% |
| 2005-12-31 | €251.77 Million ≈ $294.34 Million |
€56.54 Million ≈ $66.10 Million |
0.225x | +14.82% |
| 2004-12-31 | €234.90 Million ≈ $274.63 Million |
€45.94 Million ≈ $53.71 Million |
0.196x | -- |
About Viscofan
Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings in Spain, Rest of Europe, Middle East, Africa, Pacific Asia, North America, South America, and internationally. The company offers cellulose, collagen, fibrous, functional solutions, plastics, viscofan veggie, efan, edileaf, nutra-pharma collinstant, nutra-pharma satiscoll, and medical. It also provide… Read more